Compare KR & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KR | GEHC |
|---|---|---|
| Founded | 1883 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Chains | Computer Software: Prepackaged Software |
| Sector | Consumer Staples | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.9B | 35.8B |
| IPO Year | 2007 | 2022 |
| Metric | KR | GEHC |
|---|---|---|
| Price | $72.55 | $73.23 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 12 |
| Target Price | $73.50 | ★ $91.17 |
| AVG Volume (30 Days) | ★ 6.6M | 2.9M |
| Earning Date | 06-03-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.89% | 0.19% |
| EPS Growth | ★ 23.99 | 4.84 |
| EPS | 0.23 | ★ 4.55 |
| Revenue | ★ $147,123,000,000.00 | $20,625,000,000.00 |
| Revenue This Year | $5.52 | $7.06 |
| Revenue Next Year | $1.92 | $4.50 |
| P/E Ratio | $322.61 | ★ $16.40 |
| Revenue Growth | N/A | ★ 4.84 |
| 52 Week Low | $58.60 | $57.65 |
| 52 Week High | $74.90 | $89.77 |
| Indicator | KR | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 61.89 | 30.85 |
| Support Level | $68.11 | $69.34 |
| Resistance Level | $73.51 | $74.09 |
| Average True Range (ATR) | 1.97 | 2.17 |
| MACD | 0.35 | -0.98 |
| Stochastic Oscillator | 73.99 | 6.18 |
Kroger is one of the largest grocery retailers in the United States with about 2,700 stores across a portfolio of more than 20 supermarket banners. The company boasts an ingrained presence in US communities, citing that it is a top-two grocer in most of its major market areas. Over one fourth of Kroger's roughly $110 billion in nonperishable and fresh food sales (about 75% of revenue) stems from its private-label portfolio, of which the company manufactures about 30% of units via its own food production plants. The company also operates fuel stations and pharmacies at 60% and 80% of its locations, respectively.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).